IMMUNOHISTOCHEMISTRY CD43 Test – DNA Labs UAE
Test Name: IMMUNOHISTOCHEMISTRY CD43 Test
Components: CD43 protein detection
Price: 510.0 AED
Sample Condition: Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Site of biopsy and Clinical history.
Report Delivery: Sample Daily by 6 pm; Report Block: 5 days Tissue Biopsy: 5 days Tissue large complex: 7 days
Method: Immunohistochemistry
Test Type: Cancer
Doctor: Oncologist
Test Department: HISTOLOGY
Pre Test Information: Provide a copy of the Histopathology report, Site of biopsy and Clinical history.
Test Details
The immunohistochemistry CD43 test is a diagnostic test used in pathology to detect the presence of CD43 protein in tissue samples. CD43, also known as leukosialin or sialophorin, is a glycoprotein that is expressed on the surface of certain immune cells, including T cells, B cells, and monocytes.
The test involves staining tissue sections with specific antibodies that bind to CD43 protein. The antibodies are usually labeled with a fluorescent dye or an enzyme that produces a color reaction. The stained tissue sections are then examined under a microscope to determine the presence and distribution of CD43-positive cells.
The immunohistochemistry CD43 test is commonly used in the diagnosis and classification of lymphomas and leukemias. It can help differentiate between different types of lymphomas and leukemias based on the presence or absence of CD43 expression. CD43 expression is often used as a marker for T-cell lymphomas and leukemias.
In addition to its diagnostic applications, the immunohistochemistry CD43 test can also be used to assess the prognosis of certain cancers. Studies have shown that high CD43 expression in certain types of cancer, such as breast cancer and colorectal cancer, is associated with a poorer prognosis.
Overall, the immunohistochemistry CD43 test is a valuable tool in pathology for the detection and characterization of CD43 protein expression in tissue samples. It provides important information for the diagnosis, classification, and prognosis of various diseases, particularly lymphomas and leukemias.
| Test Name | IMMUNOHISTOCHEMISTRY CD43 Test |
|---|---|
| Components | |
| Price | 510.0 AED |
| Sample Condition | Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Site of biopsy and Clinical history. |
| Report Delivery | Sample Daily by 6 pm; Report Block: 5 days Tissue Biopsy: 5 days Tissue large complex : 7 days |
| Method | Immunohistochemistry |
| Test type | Cancer |
| Doctor | Oncologist |
| Test Department: | HISTOLOGY |
| Pre Test Information | Provide a copy of the Histopathology report, Site of biopsy and Clinical history. |
| Test Details |
The immunohistochemistry CD43 test is a diagnostic test used in pathology to detect the presence of CD43 protein in tissue samples. CD43, also known as leukosialin or sialophorin, is a glycoprotein that is expressed on the surface of certain immune cells, including T cells, B cells, and monocytes. The test involves staining tissue sections with specific antibodies that bind to CD43 protein. The antibodies are usually labeled with a fluorescent dye or an enzyme that produces a color reaction. The stained tissue sections are then examined under a microscope to determine the presence and distribution of CD43-positive cells. The immunohistochemistry CD43 test is commonly used in the diagnosis and classification of lymphomas and leukemias. It can help differentiate between different types of lymphomas and leukemias based on the presence or absence of CD43 expression. CD43 expression is often used as a marker for T-cell lymphomas and leukemias. In addition to its diagnostic applications, the immunohistochemistry CD43 test can also be used to assess the prognosis of certain cancers. Studies have shown that high CD43 expression in certain types of cancer, such as breast cancer and colorectal cancer, is associated with a poorer prognosis. Overall, the immunohistochemistry CD43 test is a valuable tool in pathology for the detection and characterization of CD43 protein expression in tissue samples. It provides important information for the diagnosis, classification, and prognosis of various diseases, particularly lymphomas and leukemias. |
